BackBetter Therapeutics- Tradeable Rights - March 2021 Overview

Better Therapeutics- Tradeable Rights - March 2021 Net Tangible Assets

Track Better Therapeutics- Tradeable Rights - March 2021's net tangible assets ($-9.9M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$-9.94M
↓ 237.02% YoYΔ $-17.19M vs prior year quarter

Peer trimmed avg / median

Loading

Better Therapeutics- Tradeable Rights - March 2021 Net Tangible Assets History

Loading

Better Therapeutics- Tradeable Rights - March 2021 vs. peers: Net Tangible Assets Comparison

Loading

Better Therapeutics- Tradeable Rights - March 2021 Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Better Therapeutics- Tradeable Rights - March 2021 (MCADR) FAQ

As of the most recent data (September 2023), MCADR shows a net tangible assets of $-9.9M. That compares with $7.3M in the prior-year period — down 237.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MCADR's net tangible assets is now $-9.9M (was $7.3M) — a 237.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Better Therapeutics- Tradeable Rights - March 2021 is outperforming or lagging.

Tracking MCADR's net tangible assets over time shows whether Better Therapeutics- Tradeable Rights - March 2021 is scaling, shrinking, or reshaping that part of the business. The current reading is $-9.9M That compares with $7.3M in the prior-year period — down 237.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Better Therapeutics- Tradeable Rights - March 2021's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $-9.9M) with ownership activity and broader fundamentals.